Match!

Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus

Published on Oct 1, 2019in Nutrition Metabolism and Cardiovascular Diseases3.34
· DOI :10.1016/j.numecd.2019.07.010
Ilaria Barchetta12
Estimated H-index: 12
(Sapienza University of Rome),
G. Ciccarelli1
Estimated H-index: 1
(Sapienza University of Rome)
+ 10 AuthorsMaria Gisella Cavallo23
Estimated H-index: 23
(Sapienza University of Rome)
Abstract
Abstract Background Dipeptidyl peptidase 4 (DPP4) is a key enzyme involved in the regulation of the incretin system exerted by cleaving the glucagon-like peptide 1 (GLP-1); the blockage of DPP4, exerted by the antidiabetic agents DPP4-inhibitors (DPP4-I), results in greater GLP-1 concentration and improved glycaemic control. DPP4 acts also as a pro-inflammatory molecule and mediates vascular damage in experimental models. The relationship between DPP4 activity and endothelial function in diabetes has not been explored yet. Aim of this study was to investigate systemic plasma DPP4 activity in relation to endothelial function in patients with type 2 diabetes mellitus (T2DM). Methods and Results Sixty-two T2DM individuals were recruited in our Diabetes outpatient clinics, Sapienza University, Rome, Italy. All participants underwent complete clinical work-up; endothelial function was evaluated by flow-mediated dilatation (FMD) test; plasma DPP4 activity was assessed by measuring the 7-amino-4-methylcoumarin (AMC) cleavage rate from the synthetic substrate H-glycyl-prolyl-AMC and compared with DPP4 activity measured in sixty-two age-, sex-, BMI-matched non-diabetic subjects. Patients with T2DM had significantly higher DPP4 activity than non-diabetic individuals (211466±87657 vs 158087±60267 nmol/min/ml, p Conclusions Circulating DPP4 activity is increased in individuals with T2DM and associated with signs of endothelial dysfunction such as impaired FMD. DPP4 may negatively affect endothelial function through mechanisms beyond glucose homeostasis and metabolic control.
  • References (52)
  • Citations (0)
📖 Papers frequently viewed together
9 Citations
16 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References52
Newest
#1Wellington Santana da Silva Júnior (UERJ: Rio de Janeiro State University)H-Index: 6
#2Maria das Graças Coelho de Souza (UERJ: Rio de Janeiro State University)H-Index: 8
Last. Luiz Guilherme Kraemer-Aguiar (UERJ: Rio de Janeiro State University)H-Index: 12
view all 5 authors...
Abstract Objective In patients with diabetes, dipeptidyl peptidase 4 (DPP4) inhibition is associated with attenuation of inflammation and endothelial dysfunction. Here, we investigated the associations between constitutive DPP4 activity, inflammatory biomarkers, and microvascular reactivity in subjects with excess body weight without diabetes. Methods Forty subjects of BMI ≥ 25.0 kg/m2 and without diabetes were cross-sectionally evaluated. We assessed microvascular blood flow and vasomotion by l...
3 CitationsSource
#1Norbert J. Tripolt (Medical University of Graz)H-Index: 7
#2Felix Aberer (Medical University of Graz)H-Index: 8
Last. Harald Sourij (Medical University of Graz)H-Index: 19
view all 14 authors...
Background Early glucose lowering intervention in subjects with type 2 diabetes mellitus was demonstrated to be beneficial in terms of micro- and macrovascular risk reduction. However, most of currently ongoing cardiovascular outcome trials are performed in subjects with manifest atherosclerosis and long-standing diabetes. Therefore, the aim of this study is to investigate the effects of the dipeptidylpeptidase-4 inhibitor linagliptin in subjects with coronary artery disease (CAD) but early type...
3 CitationsSource
#1Taku KoyamaH-Index: 2
#2Atsushi Tanaka (Saga University)H-Index: 15
Last. Koichi Node (Saga University)H-Index: 53
view all 9 authors...
Endothelial dysfunction contributes to poor cardiovascular prognosis in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD). The effect of dipeptidyl peptidase-4 inhibitors on endothelial function remains controversial. We sought to compare the effects of linagliptin and voglibose on endothelial function, as assessed by reactive hyperemia-peripheral arterial tonometry (RH-PAT). Sixteen patients with newly diagnosed T2DM and CAD were randomized 1:1 to linagliptin (5 mg...
8 CitationsSource
8 CitationsSource
#1Naga Chalasani (IU: Indiana University)H-Index: 75
#2Zobair M. YounossiH-Index: 84
Last. Arun J. Sanyal (VCU: Virginia Commonwealth University)H-Index: 102
view all 9 authors...
Abstract This guidance provides a data-supported approach to the diagnostic, therapeutic, and preventive aspects of NAFLD care. A "Guidance" document is different from a "Guideline." Guidelines are developed by a multidisciplinary panel of experts and rate the quality (level) of the evidence and the strength of each recommendation using the Grading of Recommendations, Assessment Development, and Evaluation (GRADE) system. A guidance document is developed by a panel of experts in the topic, and g...
687 CitationsSource
#1C BaumeierH-Index: 6
#2Luisa SchlüterH-Index: 2
Last. Annette SchürmannH-Index: 44
view all 12 authors...
Abstract Objective Increased hepatic expression of dipeptidyl peptidase 4 (DPP4) is associated with non-alcoholic fatty liver disease (NAFLD). Whether this is causative for the development of NAFLD is not yet clarified. Here we investigate the effect of hepatic DPP4 overexpression on the development of liver steatosis in a mouse model of diet-induced obesity. Methods Plasma DPP4 activity of subjects with or without NAFLD was analyzed. Wild-type (WT) and liver-specific Dpp4 transgenic mice ( Dpp4...
25 CitationsSource
#1Yanna Lei (Yanbian University)H-Index: 8
#2Guang Yang (Yanbian University)H-Index: 7
Last. Xian Wu ChengH-Index: 33
view all 15 authors...
Abstract Objectives Exposure to psychosocial stress is a risk factor for cardiovascular disease. Given that dipeptidyl peptidase-4 (DPP4) regulates several intracellular signaling pathways associated with glucagon-like peptide-1 (GLP-1) metabolism, we investigated the role of DPP4 in stress-related vascular senescence and atherosclerosis in apolipoprotein E -deficient (ApoE −/− ) mice. Methods and results ApoE −/− mice fed a high-fat (HF) diet were randomly assigned to one of non-stress and immo...
17 CitationsSource
#1Fumika Shigiyama (Toho University)H-Index: 3
#2Naoki Kumashiro (Toho University)H-Index: 10
Last. Takahisa Hirose (Toho University)H-Index: 29
view all 8 authors...
Introduction This multi-center, prospective, controlled, open, and randomized three-arm parallel study was designed to compare the effects of linagliptin with those of metformin on endothelial function. Materials and Methods Type 2 diabetes patients treated with 750 mg of metformin (hemoglobin A1c ≥6.0% and <8.0%, n=96) were randomized to continue metformin 750 mg/day (control group, n=29), metformin at 1500 mg/day (metformin group, n=26), and metformin 750 mg/day supplemented with linagliptin 5...
15 CitationsSource
#1Thomas W. JaxH-Index: 15
#2Alin StirbanH-Index: 2
Last. Nikolaus Marx (RWTH Aachen University)H-Index: 40
view all 9 authors...
Background Studies of dipeptidyl peptidase (DPP)-4 inhibitors report heterogeneous effects on endothelial function in patients with type 2 diabetes (T2D). This study assessed the effects of the DPP-4 inhibitor linagliptin versus the sulphonylurea glimepiride and placebo on measures of macro- and microvascular endothelial function in patients with T2D who represented a primary cardiovascular disease prevention population.
18 CitationsSource
#1Erin E. Mulvihill (Lunenfeld-Tanenbaum Research Institute)H-Index: 18
#2Elodie M. Varin (Lunenfeld-Tanenbaum Research Institute)H-Index: 3
Last. Daniel J. Drucker (U of T: University of Toronto)H-Index: 106
view all 13 authors...
Summary Pharmacological inhibition of the dipeptidyl peptidase-4 (DPP4) enzyme potentiates incretin action and is widely used to treat type 2 diabetes. Nevertheless, the precise cells and tissues critical for incretin degradation and glucose homeostasis remain unknown. Here, we use mouse genetics and pharmacologic DPP4 inhibition to identify DPP4 + cell types essential for incretin action. Although enterocyte DPP4 accounted for substantial intestinal DPP4 activity, ablation of enterocyte DPP4 in...
32 CitationsSource
Cited By0
Newest